Shares admitted to dealings on NSE Main Board from October 27, 2026 after migration from BSE SME
NSE has admitted the company's equity shares to dealings on its Capital Market Segment (Main Board) with effect from October 27, 2026, after migration from the BSE SME Platform.
By ScoutQuest · · 2 min read
- Shares admitted to dealings on NSE Main Board
- with effect from October 27, 2026, after migration from the BSE SME Platform
- Number of securities
- 254470600 equity shares of Re. 1/- each fully paid up; symbol SUDARSHAN, series EQ, market lot 1
- Lock-in details
- 128226490 shares up to 31-Dec-2027 and 9000000 shares up to 20-Feb-2028; 117244110 shares free of lock-in
What the company informed the exchanges
The company said it has received a letter from National Stock Exchange of India Limited, ref. NSE/LIST/78 dated October 23, 2026, stating that its equity shares shall be listed and admitted to dealings on the Exchange (Capital Market Segment) with effect from October 27, 2026, pursuant to migration from the SME Platform of BSE. The disclosure was made under Regulation 30 of SEBI (LODR) Regulations, 2015 and is a continuation of the company's earlier letter dated May 21, 2026.
The security in numbers
- Description: equity shares of Re. 1/- each fully paid up
- Symbol: SUDARSHAN; Series: EQ; Market lot: 1
- Number of securities: 254470600
Lock-in position as per the NSE letter
- 128226490 shares: lock-in up to 31-Dec-2027
- 9000000 shares: lock-in up to 20-Feb-2028
- 117244110 shares: Free (no lock-in)
- Total: 254470600 shares
What "migration from SME to Main Board" means
The BSE SME Platform is a segment meant for smaller companies. Migration means the company's shares move from that segment to the Capital Market Segment (Main Board) of NSE. From October 27, 2026, the shares are admitted to dealings on NSE's main board under the symbol SUDARSHAN.
What to keep in mind
- The NSE letter states the shares "shall be listed and admitted to dealings" from October 27, 2026. This is the exchange's admission of the shares to trading on its Capital Market Segment.
- A large part of the share capital carries a lock-in, and the NSE letter sets out the dates until which those shares are locked in. The remaining 117244110 shares are marked Free.
- The NSE letter asks the company to mention the symbol and series in all future correspondence and to file reports, statements and intimations through its NEAPS online update facility.
This is an update about where and from when the shares trade, along with the exchange's own record of the share count and lock-in dates.
Also from Sudarshan Pharma Industries
Acquisition proposal for 9.50% of Med Therapy Biotechnology Inc., USA stands terminated
7 Oct 2026
Completes Sale of 51% Stake in Ishwari Healthcare; Unit Ceases to Be a Subsidiary
28 Sep 2026
More numbers
- Face value per equity shareRe. 1/-
- Number of equity shares admitted to dealings on NSE254470600
- Market lot1
- Shares under lock-in up to 31-Dec-2027128226490
- Shares under lock-in up to 20-Feb-20289000000
- Shares marked free (no lock-in)117244110
- Total fully paid-up equity shares254470600
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.